Working… Menu

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02411786
Recruitment Status : Completed
First Posted : April 8, 2015
Last Update Posted : February 4, 2021
Madison Vaccines Incorporated
Information provided by (Responsible Party):
University of Wisconsin, Madison